ESS
60
-8
MPC
52
8
SLB
53
-3
ETR
68
2
NEM
48
2
SWN
77
4
FIS
46
-4
NWSA
47
-2
HSY
40
2
BIIB
37
7
CCL
68
-4
OI
43
-7
STT
51
-5
LB
38
-7
DE
53
8
INTC
43
6
GOOGL
56
2
GME
63
12
BBY
56
-2
FDX
29
-21
ESS
60
-8
MPC
52
8
SLB
53
-3
ETR
68
2
NEM
48
2
SWN
77
4
FIS
46
-4
NWSA
47
-2
HSY
40
2
BIIB
37
7
CCL
68
-4
OI
43
-7
STT
51
-5
LB
38
-7
DE
53
8
INTC
43
6
GOOGL
56
2
GME
63
12
BBY
56
-2
FDX
29
-21
Financhill
Back

Spirit AeroSystems Holdings Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
35

SPR
Spirit AeroSystems Holdings

Last Price:
33.10
Seasonality Move:
8.12%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
35
Spirit AeroSystems Holdings (SPR) is a Sell

Is Spirit AeroSystems Holdings a Buy, Sell or Hold?

  • The current Spirit AeroSystems Holdings [SPR] share price is $33.12. The Score for SPR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • SPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SPR Stock Price Chart

What is Spirit AeroSystems Holdings's stock price today?

  • The Spirit AeroSystems Holdings share price today is $33.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 43.37 Sell
Chaikin Money Flow: 1464031 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.15 - 34.91) Sell
Bollinger Bands (100): (31.16 - 34.92) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

SPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.18 Sell
20-day SMA: 33.8 Sell
50-day SMA: 34.42 Sell
200-day SMA: 31.98 Buy
8-day EMA: 33.16 Sell
20-day EMA: 33.59 Sell
50-day EMA: 33.8 Sell
200-day EMA: 31.82 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Spirit AeroSystems Holdings Earnings Growth & SPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.08 per share, an increase next quarter of $0.84 per share, a decrease this year of $3.42 per share, and an increase next year of $8.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Spirit AeroSystems Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):